LRI Investments LLC Has $172,000 Stake in AdaptHealth Corp. (NASDAQ:AHCO)

LRI Investments LLC increased its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 32.0% in the third quarter, Holdings Channel.com reports. The firm owned 15,331 shares of the company’s stock after purchasing an additional 3,713 shares during the quarter. LRI Investments LLC’s holdings in AdaptHealth were worth $172,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Virtus Investment Advisers Inc. acquired a new position in shares of AdaptHealth during the third quarter worth about $346,000. State Street Corp lifted its stake in AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after acquiring an additional 681,816 shares in the last quarter. Systematic Financial Management LP acquired a new position in AdaptHealth during the 3rd quarter worth approximately $1,111,000. Quarry LP grew its stake in shares of AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after acquiring an additional 5,838 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of AdaptHealth by 7.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 162,470 shares of the company’s stock valued at $1,825,000 after purchasing an additional 11,757 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Trading Up 0.7 %

AdaptHealth stock opened at $9.54 on Wednesday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock has a 50-day simple moving average of $10.23 and a 200 day simple moving average of $10.46. The stock has a market capitalization of $1.28 billion, a P/E ratio of -5.78, a PEG ratio of 1.37 and a beta of 1.10. AdaptHealth Corp. has a 52 week low of $6.43 and a 52 week high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business had revenue of $805.90 million for the quarter, compared to analyst estimates of $809.32 million. During the same period in the previous year, the firm posted $0.19 earnings per share. The firm’s revenue was up .2% compared to the same quarter last year. Analysts expect that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

Insider Activity

In other news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now owns 212,611 shares in the company, valued at approximately $2,389,747.64. This trade represents a 10.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on AHCO. Truist Financial decreased their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, November 15th. Canaccord Genuity Group lowered their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Robert W. Baird reduced their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. UBS Group lowered their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada dropped their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $11.67.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.